Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Alt Biotech Wins Award for Eco-Friendly Cell Culture Tech
Biotech & Bioprocessing Alt Biotech Wins Award for Eco-Friendly Cell Culture Tech

Paris-based startup Alt Biotech has recently caught the eye of the biotech industry through an impressive victory in an innovation competition sponsored by INTEGRA. At the helm of this groundbreaking company is Dr. Jade Pellet, the co-founder and Chief Scientific Officer, who is spearheading the

Cambridge Early Cancer Institute Receives £11m Anonymous Donation
Research & Development Cambridge Early Cancer Institute Receives £11m Anonymous Donation

Battling the scourge of cancer remains a critical challenge in healthcare, particularly in catching the disease in its nascent stages when treatment options have a higher chance of success. The fight has been significantly strengthened at the University of Cambridge, thanks to a substantial £11

Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?
Management & Regulatory Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?

To escalate the war on cancer, Sutro Biopharma has launched a public offering with the goal of raising $75 million. These proceeds are set to bolster Sutro's efforts in creating cutting-edge antibody-drug conjugates (ADCs), which stand at the forefront of its cancer treatment research. By

Residue Control in Biopharma: ACRO Unveils resDetect™ Solutions
Management & Regulatory Residue Control in Biopharma: ACRO Unveils resDetect™ Solutions

The Imperative for High-Quality Control in Biomanufacturing In the ever-evolving landscape of biopharmaceutical manufacturing, the imperative for maintaining high-quality control measures is unarguable. With the introduction of complex biological materials into gene therapies and vaccine

Biomanufacturing's Third Wave: Navigating New Complexities
Management & Regulatory Biomanufacturing's Third Wave: Navigating New Complexities

At the recent BPI Europe 2024 conference, a landmark discussion led by Uwe Buecheler from Boehringer Ingelheim marked the dawn of a new chapter in biopharmaceuticals. Described as the 'third wave' of biologics, it signifies an era brimming with groundbreaking therapeutic innovations that

How Do State Privacy Laws Evolve Across the US?
Management & Regulatory How Do State Privacy Laws Evolve Across the US?

The swift advancement of technology has raised significant concerns about the protection of personal data. In response, the United States is seeing an increasingly diverse collection of state-enacted privacy laws. With federal action lagging, individual states are crafting their own regulatory

Is the DEA Stalling Cannabis Research through Bureaucracy?
Management & Regulatory Is the DEA Stalling Cannabis Research through Bureaucracy?

The pursuit of understanding the medical benefits of cannabis continues to evolve as researchers like those at MMJ BioPharma Cultivation Inc. face significant bureaucratic resistance, particularly from federal institutions such as the DEA. The company’s recent lawsuit highlights the extensive c

How Is Exblifep Reinventing UTI and Pneumonia Treatment?
Management & Regulatory How Is Exblifep Reinventing UTI and Pneumonia Treatment?

The realm of antibiotic therapy is witnessing a remarkable transformation with the UK's MHRA's endorsement of Exblifep, a novel medical intervention for the management of sophisticated urinary tract infections (UTIs) and select instances of pneumonia. Originating from Advanz Pharma's

How Did Pfizer's Social Media Post Violate UK Regulations?
Management & Regulatory How Did Pfizer's Social Media Post Violate UK Regulations?

The intersection of social media and pharmaceutical regulation hit a flashpoint when Pfizer, a leading company in COVID-19 vaccine development, faced repercussions for a seemingly innocuous tweet. While social networks provide a powerful platform for sharing news and advancements, they also raise

How Is AI Changing Cardiac Imaging with Handheld Ultrasounds?
Tech & Innovation How Is AI Changing Cardiac Imaging with Handheld Ultrasounds?

Revolutionizing Point of Care Diagnostics Artificial Intelligence (AI) is rapidly transforming the medical field, with one of its most significant impacts being in the domain of cardiac imaging. The integration of AI technology with handheld ultrasound devices is enabling clinicians to perform

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later